Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 01, 2012 (Vol. 32, No. 7)

Regenerative Medicine Looks to the Future

  • After nearly a decade-long federal moratorium on embryonic stem cell research, regenerative medicine took a serious hit. Yet sometimes from adversity comes innovation. Like-minded regenerative medicine industry leaders illustrated this point at the recent “New York Stem Cell” summit. With novel cell lines involving pure pluripotent embryonic progenitors and ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.